PT1227797E - Formulacoes farmaceuticas de dispersao solida - Google Patents
Formulacoes farmaceuticas de dispersao solidaInfo
- Publication number
- PT1227797E PT1227797E PT00977140T PT00977140T PT1227797E PT 1227797 E PT1227797 E PT 1227797E PT 00977140 T PT00977140 T PT 00977140T PT 00977140 T PT00977140 T PT 00977140T PT 1227797 E PT1227797 E PT 1227797E
- Authority
- PT
- Portugal
- Prior art keywords
- solid dispersion
- pharmaceutical formulations
- disclosed
- methods
- soliddispersion
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
- A61K9/146—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Virology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Tropical Medicine & Parasitology (AREA)
- AIDS & HIV (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US43951499A | 1999-11-12 | 1999-11-12 |
Publications (1)
Publication Number | Publication Date |
---|---|
PT1227797E true PT1227797E (pt) | 2005-05-31 |
Family
ID=23745019
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PT00977140T PT1227797E (pt) | 1999-11-12 | 2000-11-10 | Formulacoes farmaceuticas de dispersao solida |
Country Status (10)
Country | Link |
---|---|
EP (1) | EP1227797B1 (pt) |
JP (1) | JP4815085B2 (pt) |
AT (1) | ATE286720T1 (pt) |
CA (1) | CA2390092C (pt) |
DE (1) | DE60017444T2 (pt) |
DK (1) | DK1227797T3 (pt) |
ES (1) | ES2235991T3 (pt) |
MX (1) | MXPA02004739A (pt) |
PT (1) | PT1227797E (pt) |
WO (1) | WO2001034118A2 (pt) |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2001034119A2 (en) | 1999-11-12 | 2001-05-17 | Abbott Laboratories | Inhibitors of crystallization in a solid dispersion |
DE10026698A1 (de) | 2000-05-30 | 2001-12-06 | Basf Ag | Selbstemulgierende Wirkstoffformulierung und Verwendung dieser Formulierung |
MXPA03009971A (es) * | 2001-05-03 | 2004-02-12 | Hoffmann La Roche | FORMA DE DOSIFICACIoN FARMACEUTICA DE MESILATO DE NELFINAVIR AMORFO. |
US8025899B2 (en) | 2003-08-28 | 2011-09-27 | Abbott Laboratories | Solid pharmaceutical dosage form |
US20050048112A1 (en) | 2003-08-28 | 2005-03-03 | Jorg Breitenbach | Solid pharmaceutical dosage form |
US8377952B2 (en) | 2003-08-28 | 2013-02-19 | Abbott Laboratories | Solid pharmaceutical dosage formulation |
BRPI0418330A (pt) | 2003-12-31 | 2007-05-02 | Pfizer Prod Inc | composições sólidas de drogas de solubilidade baixa e poloxámeros |
MY146557A (en) * | 2006-12-22 | 2012-08-30 | Yuhan Corp | Revaprazan-containing solid dispersion and process for the preparation thereof |
JP5593013B2 (ja) * | 2007-04-20 | 2014-09-17 | 株式会社感光社 | 固体型殺菌剤及び人体施用組成物 |
WO2010070611A1 (en) | 2008-12-18 | 2010-06-24 | Ranbaxy Laboratories Limited | Atazanavir formulations |
US9096556B2 (en) | 2011-05-27 | 2015-08-04 | Hetero Research Foundation | Amorphous ritonavir co-precipitated |
EP3569225A1 (en) | 2018-05-18 | 2019-11-20 | Pharmaceutical Oriented Services Ltd | Solid dispersion containing ritonavir |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IL110752A (en) * | 1993-09-13 | 2000-07-26 | Abbott Lab | Liquid semi-solid or solid pharmaceutical composition for an HIV protease inhibitor |
-
2000
- 2000-11-10 MX MXPA02004739A patent/MXPA02004739A/es active IP Right Grant
- 2000-11-10 CA CA002390092A patent/CA2390092C/en not_active Expired - Lifetime
- 2000-11-10 AT AT00977140T patent/ATE286720T1/de active
- 2000-11-10 WO PCT/US2000/030910 patent/WO2001034118A2/en active IP Right Grant
- 2000-11-10 JP JP2001536118A patent/JP4815085B2/ja not_active Expired - Lifetime
- 2000-11-10 DE DE60017444T patent/DE60017444T2/de not_active Expired - Lifetime
- 2000-11-10 ES ES00977140T patent/ES2235991T3/es not_active Expired - Lifetime
- 2000-11-10 EP EP00977140A patent/EP1227797B1/en not_active Revoked
- 2000-11-10 DK DK00977140T patent/DK1227797T3/da active
- 2000-11-10 PT PT00977140T patent/PT1227797E/pt unknown
Also Published As
Publication number | Publication date |
---|---|
WO2001034118A3 (en) | 2002-01-10 |
MXPA02004739A (es) | 2003-01-28 |
CA2390092C (en) | 2009-07-14 |
DE60017444D1 (de) | 2005-02-17 |
EP1227797B1 (en) | 2005-01-12 |
ES2235991T3 (es) | 2005-07-16 |
CA2390092A1 (en) | 2001-05-17 |
DK1227797T3 (da) | 2005-05-30 |
JP2003530310A (ja) | 2003-10-14 |
DE60017444T2 (de) | 2006-02-09 |
JP4815085B2 (ja) | 2011-11-16 |
ATE286720T1 (de) | 2005-01-15 |
WO2001034118A2 (en) | 2001-05-17 |
EP1227797A2 (en) | 2002-08-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2001034119A3 (en) | Inhibitors of crystallization in a solid dispersion | |
CA2322315A1 (en) | Fast disintegrating tablets | |
DE60121570D1 (de) | Oral anzuwendende schnell zerfallende feste darreichungsformen | |
PT1227797E (pt) | Formulacoes farmaceuticas de dispersao solida | |
WO2003080023A3 (en) | Fast dissolving dosage forms having reduced friability | |
AR024384A1 (es) | UNA FORMA DE DOSIFICACIoN FARMACÉUTICA DE DISOLUCIoN INSTANTÁNEA Y UN MÉTODO PARA PREPARARLA | |
WO2004100857A3 (en) | Highly plastic granules for making fast melting tablets | |
WO1998009597A3 (en) | Cushioning beads and tablet comprising the same capable of forming a suspension | |
MX358033B (es) | Forma de dosificación farmacéutica sólida que comprende al menos un inhibidor de proteasa de hiv. | |
FI20011851A (fi) | Fluoksetiinia tai sen happoadditiosuolaa sisältävä dispergoituva tabletti | |
NO20001042D0 (no) | Oftalmiske preparater med forsinket frigivelse inneholdende vannoppløselige medikamenter | |
CA2271196A1 (en) | Pharmaceutical compositions of hiv protease inhibitors with improved oral bioavailability | |
IS5577A (is) | Omeprazól örkorn vernduð gegn magasýrum, framleiðsluferli og lyfjasamsetningar | |
WO2000040205A3 (en) | Sustained release formulation with reduced moisture sensitivity | |
MY127908A (en) | Improved pharmaceutical formulations. | |
HK1040920A1 (en) | Sustained release pharmaceutical composition and method of releasing pharmaceutically active agent. | |
MY119722A (en) | Swallow tablet comprising paracetamol. | |
MY136059A (en) | Swallow tablet comprising paracetamol | |
MXPA04003506A (es) | Metodo para la preparacion de una composicion farmaceutica que comprende acido 5-aminosalicilico para el uso en el tratamiento de la colitis ulcerativa y de la enfermedad de crohn. | |
ATE248588T1 (de) | Geschmacksmaskierte zubereitungen | |
PT1263413E (pt) | Metodo de preparacao de dispersoes solidas | |
SE0001916D0 (sv) | Novel formulation | |
MXPA01008348A (es) | Microcapsulas para la liberacion prolongada de farmacos. | |
AR034435A1 (es) | Agentes terapeuticos. | |
DK1349543T3 (da) | Fremgangsmåde til fremstilling af tabletter af planteekstrakter |